Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Multidrug Resistance-Associated Protein 2 Is Primarily Responsible for the Biliary Excretion of Fexofenadine in Mice

Xianbin Tian, Maciej J. Zamek-Gliszczynski, Jun Li, Arlene S. Bridges, Ken-ichi Nezasa, Nita J. Patel, Thomas J. Raub and Kim L. R. Brouwer
Drug Metabolism and Disposition January 2008, 36 (1) 61-64; DOI: https://doi.org/10.1124/dmd.107.017319
Xianbin Tian
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maciej J. Zamek-Gliszczynski
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun Li
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arlene S. Bridges
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken-ichi Nezasa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nita J. Patel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas J. Raub
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kim L. R. Brouwer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 36 no. 1 61-64
DOI 
https://doi.org/10.1124/dmd.107.017319
PubMed 
17913796

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received June 20, 2007
  • Accepted October 1, 2007
  • Published online December 26, 2007.

Article Versions

  • Earlier version (October 3, 2007 - 06:13).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Xianbin Tian,
  2. Maciej J. Zamek-Gliszczynski,
  3. Jun Li,
  4. Arlene S. Bridges,
  5. Ken-ichi Nezasa,
  6. Nita J. Patel,
  7. Thomas J. Raub and
  8. Kim L. R. Brouwer
  1. School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (X.T., M.J.Z.-G., J.L., A.S.B., K.N., K.L.R.B.); and Eli Lilly and Company, Drug Disposition, Indianapolis, Indiana (N.J.P., T.J.R.)
  1. Address correspondence to:
    Dr. Kim L. R. Brouwer, School of Pharmacy, C.B. #7360 Kerr Hall, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7360. E-mail: kbrouwer{at}unc.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to March 2023

AbstractFullPdf
Aug 201712110
Sep 20171183
Oct 20172292
Nov 20170695
Dec 201711712
Jan 201821475
Feb 201851102
Mar 20184655
Apr 20180342
May 20186323
Jun 20182286
Jul 20180152
Aug 20180154
Sep 20180192
Oct 20180352
Nov 20182473
Dec 201834127
Jan 20193414
Feb 20192500
Mar 20192021
Apr 2019901
May 20191423
Jun 2019314
Jul 20191401
Aug 20191612
Oct 20191101
Nov 20192201
Dec 20191476
Jan 20201714
Feb 20201211
Mar 2020811
May 2020302
Jun 20201200
Jul 20201300
Aug 20201002
Sep 20201040
Oct 202021122
Nov 20201225
Dec 2020721
Jan 202117134
Feb 202113129
Mar 2021842
Apr 2021963
May 20211640
Jun 2021971
Jul 20211335
Aug 2021731
Sep 20211140
Oct 2021812
Nov 20212013
Dec 20211964
Jan 2022943
Feb 20221421
Mar 2022611
Apr 2022841
May 20221911
Jun 20221110
Jul 20221628
Aug 20221345
Sep 20221371
Oct 202211103
Nov 20221225
Dec 20221022
Jan 20232861
Feb 20231845
Mar 20231221

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 36 (1)
Drug Metabolism and Disposition
Vol. 36, Issue 1
1 Jan 2008
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Multidrug Resistance-Associated Protein 2 Is Primarily Responsible for the Biliary Excretion of Fexofenadine in Mice
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Multidrug Resistance-Associated Protein 2 Is Primarily Responsible for the Biliary Excretion of Fexofenadine in Mice

Xianbin Tian, Maciej J. Zamek-Gliszczynski, Jun Li, Arlene S. Bridges, Ken-ichi Nezasa, Nita J. Patel, Thomas J. Raub and Kim L. R. Brouwer
Drug Metabolism and Disposition January 1, 2008, 36 (1) 61-64; DOI: https://doi.org/10.1124/dmd.107.017319

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Multidrug Resistance-Associated Protein 2 Is Primarily Responsible for the Biliary Excretion of Fexofenadine in Mice

Xianbin Tian, Maciej J. Zamek-Gliszczynski, Jun Li, Arlene S. Bridges, Ken-ichi Nezasa, Nita J. Patel, Thomas J. Raub and Kim L. R. Brouwer
Drug Metabolism and Disposition January 1, 2008, 36 (1) 61-64; DOI: https://doi.org/10.1124/dmd.107.017319
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results and Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • A PBPK model for CBD in adults and children
  • Mass Balance Recovery and Disposition of AZD4831 in Humans
  • Biotransformation of AZD4831 in Animals and Humans
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics